149 related articles for article (PubMed ID: 30526533)
21. Modelling the effects of standard prognostic factors in node-positive breast cancer. German Breast Cancer Study Group (GBSG).
Sauerbrei W; Royston P; Bojar H; Schmoor C; Schumacher M
Br J Cancer; 1999 Apr; 79(11-12):1752-60. PubMed ID: 10206288
[TBL] [Abstract][Full Text] [Related]
22. A Novel Breast Cancer Index for Prediction of Distant Recurrence in HR
Zhang Y; Schroeder BE; Jerevall PL; Ly A; Nolan H; Schnabel CA; Sgroi DC
Clin Cancer Res; 2017 Dec; 23(23):7217-7224. PubMed ID: 28939745
[No Abstract] [Full Text] [Related]
23. Predicting likelihood of having four or more positive nodes in patient with sentinel lymph node-positive breast cancer: a nomogram validation study.
Unal B; Gur AS; Beriwal S; Tang G; Johnson R; Ahrendt G; Bonaventura M; Soran A
Int J Radiat Oncol Biol Phys; 2009 Nov; 75(4):1035-40. PubMed ID: 19327916
[TBL] [Abstract][Full Text] [Related]
24. An updated PREDICT breast cancer prognostication and treatment benefit prediction model with independent validation.
Candido Dos Reis FJ; Wishart GC; Dicks EM; Greenberg D; Rashbass J; Schmidt MK; van den Broek AJ; Ellis IO; Green A; Rakha E; Maishman T; Eccles DM; Pharoah PDP
Breast Cancer Res; 2017 May; 19(1):58. PubMed ID: 28532503
[TBL] [Abstract][Full Text] [Related]
25. Updated postoperative nomogram incorporating the number of positive lymph nodes to predict disease recurrence following radical prostatectomy.
Nguyen DP; Kent M; Vilaseca A; Corradi RB; Fossati N; Sjoberg DD; Benfante N; Eastham JA; Scardino PT; Touijer KA
Prostate Cancer Prostatic Dis; 2017 Mar; 20(1):105-109. PubMed ID: 27958385
[TBL] [Abstract][Full Text] [Related]
26. Nodal ratio of positive to excised nodes, but not number of positive lymph nodes is better to predict group to avoid chemotherapy among postmenopausal ER-positive, lymph node-positive T1-T2 breast cancer patients.
Jia XQ; Hong Q; Cheng JY; Li JW; Wang YJ; Mo M; Shao ZM; Shen ZZ; Liu GY
J Cancer Res Ther; 2015; 11(4):740-5. PubMed ID: 26881511
[TBL] [Abstract][Full Text] [Related]
27. Number of metastatic lymph nodes as determinant of outcome after salvage radical prostatectomy for radiation-recurrent prostate cancer.
Gugliemetti G; Sukhu R; Conca Baenas MA; Meeks J; Sjoberg DD; Eastham JA; Scardino PT; Touijer K
Actas Urol Esp; 2016 Sep; 40(7):434-9. PubMed ID: 27184342
[TBL] [Abstract][Full Text] [Related]
28. Predicting loco-regional recurrence risk in T1, T2 breast cancer with 1-3 positive axillary nodes postmastectomy: Development of a predictive nomogram.
Wadasadawala T; Kannan S; Gudi S; Rishi A; Budrukkar A; Parmar V; Shet T; Desai S; Gupta S; Badwe R; Sarin R
Indian J Cancer; 2017; 54(1):352-357. PubMed ID: 29199721
[TBL] [Abstract][Full Text] [Related]
29. Evaluation of clinical parameters influencing the development of bone metastasis in breast cancer.
Diessner J; Wischnewsky M; Stüber T; Stein R; Krockenberger M; Häusler S; Janni W; Kreienberg R; Blettner M; Schwentner L; Wöckel A; Bartmann C
BMC Cancer; 2016 May; 16():307. PubMed ID: 27175930
[TBL] [Abstract][Full Text] [Related]
30. Metastasis-free interval in breast cancer patients: Thirty-year trends and time dependency of prognostic factors. A retrospective analysis based on a single institution experience.
Houzé de l'Aulnoit A; Rogoz B; Pinçon C; Houzé de l'Aulnoit D
Breast; 2018 Feb; 37():80-88. PubMed ID: 29102782
[TBL] [Abstract][Full Text] [Related]
31. Prognostic significance of apex axillary invasion for locoregional recurrence and effect of postmastectomy radiotherapy on overall survival in node-positive breast cancer patients.
Kuru B; Camlibel M; Dinc S; Gulcelik MA; Alagol H
World J Surg; 2004 Mar; 28(3):236-41. PubMed ID: 14961194
[TBL] [Abstract][Full Text] [Related]
32. Tree-based model for breast cancer prognostication.
Banerjee M; George J; Song EY; Roy A; Hryniuk W
J Clin Oncol; 2004 Jul; 22(13):2567-75. PubMed ID: 15226324
[TBL] [Abstract][Full Text] [Related]
33. Ratio between positive lymph nodes and total excised axillary lymph nodes as an independent prognostic factor for overall survival in patients with nonmetastatic lymph node-positive breast cancer.
Hatoum HA; Jamali FR; El-Saghir NS; Musallam KM; Seoud M; Dimassi H; Abbas J; Khalife M; Boulos FI; Tawil AN; Geara FB; Salem Z; Shamseddine AA; Al-Feghali K; Shamseddine AI
Ann Surg Oncol; 2009 Dec; 16(12):3388-95. PubMed ID: 19655200
[TBL] [Abstract][Full Text] [Related]
34. Patients with recurrent breast cancer: does the primary axillary lymph node status predict more aggressive tumor progression?
Rack B; Janni W; Gerber B; Strobl B; Schindlbeck C; Klanner E; Rammel G; Sommer H; Dimpfl T; Friese K
Breast Cancer Res Treat; 2003 Nov; 82(2):83-92. PubMed ID: 14692652
[TBL] [Abstract][Full Text] [Related]
35. Predictors of non-sentinel lymph node metastasis in breast cancer patients.
Goyal A; Douglas-Jones A; Newcombe RG; Mansel RE;
Eur J Cancer; 2004 Jul; 40(11):1731-7. PubMed ID: 15251163
[TBL] [Abstract][Full Text] [Related]
36. Nodal Ratio as a Prognostic Factor in Patients with Four or More Positive Axillary Nodes Treated with Breast-conserving Therapy and Regional Nodal Irradiation.
Iatì G; Pontoriero A; Mondello S; Santacaterina A; Platania A; Frosina P; Raso MM; Aiello D; Arcudi A; Arena G; Marino G; Mazzei M; Rifatto C; Risoleti E; Runco R; Sansotta G; Delia P; Sindoni A; Pergolizzi S
Anticancer Res; 2016 Jul; 36(7):3549-54. PubMed ID: 27354622
[TBL] [Abstract][Full Text] [Related]
37. Breast cancer-specific survival in patients with lymph node-positive hormone receptor-positive invasive breast cancer and Oncotype DX Recurrence Score results in the SEER database.
Roberts MC; Miller DP; Shak S; Petkov VI
Breast Cancer Res Treat; 2017 Jun; 163(2):303-310. PubMed ID: 28243896
[TBL] [Abstract][Full Text] [Related]
38. 259 Patients with DCIS of the breast applying USC/Van Nuys prognostic index: a retrospective review with long term follow up.
Di Saverio S; Catena F; Santini D; Ansaloni L; Fogacci T; Mignani S; Leone A; Gazzotti F; Gagliardi S; De Cataldis A; Taffurelli M
Breast Cancer Res Treat; 2008 Jun; 109(3):405-16. PubMed ID: 17687650
[TBL] [Abstract][Full Text] [Related]
39. Ascertaining prognosis for breast cancer in node-negative patients with innovative survival analysis.
Chapman JA; Lickley HL; Trudeau ME; Hanna WM; Kahn HJ; Murray D; Sawka CA; Mobbs BG; McCready DR; Pritchard KI
Breast J; 2006; 12(1):37-47. PubMed ID: 16409585
[TBL] [Abstract][Full Text] [Related]
40. Absent progesterone receptor expression in the lymph node metastases of ER-positive, HER2-negative breast cancer is associated with relapse on tamoxifen.
Snell CE; Gough M; Middleton K; Hsieh M; Furnas L; Seidl B; Gibbons K; Pyke C; Shannon C; Woodward N; Armes JE
J Clin Pathol; 2017 Nov; 70(11):954-960. PubMed ID: 28416639
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
